טוען...
Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system
Osteosarcoma is the most common type primary malignant tumor of bone. Patients with regional osteosarcoma are routinely treated with surgery and chemotherapy. In addition, many patients with metastatic or recurrent osteosarcoma show poor prognosis with current chemotherapy agents. Therefore, it is i...
שמור ב:
| הוצא לאור ב: | J Orthop Res |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4304907/ https://ncbi.nlm.nih.gov/pubmed/25348612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jor.22745 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|